Allogene Therapeutics falls after trial delay, rating downgrade post Q1 results Allogene Therapeutics falls after trial delay, rating downgrade post Q1 results Post ContentalloRead More You might also be interested in reading AbbVie, Neomorph to develop molecular glue degraders. May 14, 2025 In Mainstream ← Previous post Next post →